Neuraxis Metastases Of Primary Central Nervous System Tumors: A Review Of Clinicopathological And Radiographic Characters Of 198 Cases In A Single Center

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Gleissner B, Chamberlain MC. Neoplastic meningitis. Lancet Oncol. 2006;5:443–452.
   Google Scholar
• Wang N, Bertalan MS, Brastianos PK. Leptomeningeal metastasis from systemic cancers: review and update on management. Cancer. 2018;124:21–35. doi:10.1002/cncr.3091129165794
   PubMed Web of Science ®Google Scholar
• Hyun JW, Jeong IH, Joung AR, et al. Leptomeningeal metastasis: clinical experience of 519 cases. Eur J Cancer. 2016;56:107–114. doi:10.1016/j.ejca.2015.12.02126841095
   PubMed Web of Science ®Google Scholar
• Kesari S, Batchelor TT. Leptomeningeal metastases. Neurol Clin N Am. 2003;21(5):25–66. doi:10.1016/S0733-8619(02)00032-4
   PubMedGoogle Scholar
• Bordignon KC, Neto MC, Ramina R, et al. Patterns of neuraxis dissemination of gliomas: suggestion of a classification based on magnetic resonance imaging findings. Surg Neurol. 2006;65:472–477. doi:10.1016/j.surneu.2005.08.01916630907
   PubMedGoogle Scholar
• Gangadhar K, Santhosh D. Radiopathlogical evaluation of primary malignant skull tumors: a review. Clin Neurol Neurosurg. 2012;114:833–839. doi:10.1016/j.clineuro.2012.05.04122721775
   PubMed Web of Science ®Google Scholar
• Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology. 2010;74:1449–1454. doi:10.1212/WNL.0b013e3181dc1a6920439847
   PubMed Web of Science ®Google Scholar
• Zhang MS, Wang ZY, Zhang JP, et al. Metastases in cerebellopontine angle from the tumors of the central nervous system. J Clin Neurosci. 2017;42:84–90. doi:10.1016/j.jocn.2017.04.01128442197
   PubMed Web of Science ®Google Scholar
• Barajas RF, Cha S. Metastasis in adult brain tumors. Neuroimage Clin N Am. 2016;26:601–620. doi:10.1016/j.nic.2016.06.008
   PubMed Web of Science ®Google Scholar
• Faria AV, Azevedo GA, Zanardi VA, Ghizoni E, Queiroz LS. Dissemination patterns of pilocytic astrocytoma. Clin Neurol Neurosurg. 2006;108:568–572. doi:10.1016/j.clineuro.2005.01.00616905433
   PubMed Web of Science ®Google Scholar
• Beauchesne P. Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumors. Lancet Oncol. 2010;11:871–879. doi:10.1016/S1470-2045(10)70034-620598636
   PubMed Web of Science ®Google Scholar
• Herrlinger U, Foschler H, Kuker W, et al. Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurolog Sci. 2004;223:167–178. doi:10.1016/j.jns.2004.05.008
   PubMed Web of Science ®Google Scholar
• Umemura S, Tsubouchi K, Yoshioka H, et al. Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: okayama lung cancer study group. Lung Cancer. 2012;77:134–139. doi:10.1016/j.lungcan.2012.03.00222487432
   PubMed Web of Science ®Google Scholar
• Assi HI, Mahmoud T, Saadeh FS, Darsa HE. Management of leptomeningeal metastasis in breast cancer. Clin Neurol Neurosurg. 2018;172:151–159. doi:10.1016/j.clineuro.2018.07.00130015053
   PubMed Web of Science ®Google Scholar
• Tremont-Lukats IW, Bobustuc G, Lagos G, Lolas K, Kyritsis AP, Puduvalli VK. Brain metastasis from prostate carcinoma: the M.D. Anderson Cancer Center experience. Cancer. 2003;15:363–368. doi:10.1002/cncr.11522
   Google Scholar
• Oechsle K, Lange-Brock V, Kruell A, Bokemeyer C, Wit MD. Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. J Cancer Res Clin Oncol. 2010;136:1729–1735. doi:10.1007/s00432-010-0831-x20204406
   PubMed Web of Science ®Google Scholar
• Waki F, Ando M, Takashima A, et al. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol. 2009;93:205012. doi:10.1007/s11060-008-9758-3
   Web of Science ®Google Scholar
• Nabors LB, Porthow J, Ammirati M, et al. Central nervous system cancers, version 1. 2015. J Natl Compr Canc Netw. 2015;13:1191–1202. doi:10.6004/jnccn.2015.014826483059
   PubMed Web of Science ®Google Scholar
• Cheng HY, Perez-Soler R. Leptomeningeal metastases in non-small-cell lung cancer. Lancet Oncol. 2018;19:e43–e55. doi:10.1016/S1470-2045(17)30689-729304362
   PubMed Web of Science ®Google Scholar
• Chamberlain MC, Junck L, Brandsma D, et al. Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol. 2017;19:484–492. doi:10.1093/neuonc/now18328039364
   PubMed Web of Science ®Google Scholar
• Zhang MS, Ou YW, Zhang HW, et al. Leptomeningeal metastases from central nervous system tumors: a study of classification and stage in the spinal cord of 58 patients. Chin Sci Bull. 2012;57:2914–2919. doi:10.1007/s11434-012-5262-4
   Google Scholar
• Sanan A, van Loveren HR. The arachnoid and the myth of Arachne. Neurosurgery. 1999;45:152–155. doi:10.1097/00006123-199907000-0003410414578
   PubMed Web of Science ®Google Scholar
• Haines DE, Frederickson GR. The meninges In: Al-Mefty O, editor. Meningiomas. New York: Raven Press; 1991:9–25.
   Google Scholar
• Chamberlain MC. Neoplastic meningitis. J Clin Oncol. 2005;23:3605–3613. doi:10.1200/JCO.2005.01.13115908671
   PubMed Web of Science ®Google Scholar
• Perkins SM, Shinohara ET, DeWee T, Frangoul H. Outcome for children with metastatic solid tumors over the last four decades. PLoS One. 2014;9:e1000396. doi:10.1371/journal.pone.0100396
   Web of Science ®Google Scholar
• US Department of Health and Human Service, US National Institute of Health, US National Cancer Institute, Adolescent and Young Adult Oncology Progress Report Group. Closing the gap: research and care imperative for adolescents and young adults with cancer; 2015.
   Google Scholar
• Brower JV, Saha S, Rosenberg SA, Hullett CR, Robins HI. Management of leptomeningeal metastases: prognostic factors and associated outcomes. J Clin Neurosci. 2016;27:130–137. doi:10.1016/j.jocn.2015.11.01226778048
   PubMed Web of Science ®Google Scholar
• Groves MD. New strategies in the management of leptomeningeal metastasis. Arch Neurol. 2010;67:305–312. doi:10.1001/archneurol.2010.1820212228
   PubMedGoogle Scholar
• Chamberlain MC, Glantz M, Grove MD, Wilson WH. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol. 2009;36:S35–S45. doi:10.1053/j.seminoncol.2009.05.00519660682
   PubMed Web of Science ®Google Scholar
• Gururangan S, McLaughlin CA, Brashear J, et al. Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma. J Neurooncol. 2006;77:207–212. doi:10.1007/s11060-005-9029-516568209
   PubMed Web of Science ®Google Scholar
• Chamberlain MC, Soffietti R, Raizer J, et al. Leptomeningeal metastasis: a response assessment in neuro-oncology critical review of endpoints and response criteria of published randomized clinical trials. Neuro Oncol. 2014;16:1176–1185. doi:10.1093/neuonc/nou08924867803
   PubMed Web of Science ®Google Scholar
• O’Meara WP, Borkar SA, Stambuk HE, Lymberis SC. Leptomeningeal metastasis. Curr Probl Cancer. 2007;31:367–424. doi:10.1016/j.currproblcancer.2007.07.00118035183
   PubMedGoogle Scholar
• Melisko ME, Glantz M, Rugo HS. New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer. Nat Clin Pract Oncol. 2009;6:25–33. doi:10.1038/ncponc124318936791
   PubMedGoogle Scholar
• Glantz MJ, Cole BF, Recht L, et al. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol. 1998;16:1561–1567. doi:10.1200/JCO.1998.16.4.15619552066
   PubMed Web of Science ®Google Scholar
• Biasco G, Pantaleo MA, Casadei S. Treatment of brain metastases of malignant melanoma with temozolomide. N Engl J Med. 2010;345:621–622. doi:10.1056/NEJM200108233450817
   Google Scholar